Williams PC, Howard-Jones A, Butters C, Koirala A, Britton PN, Duguid R, Wijeratne P, Johnson N, Jayasinghe S. Clinical and epidemiologic profile of invasive pneumococcal disease in Australian children following the relaxation of nonpharmaceutical interventions against SARS-COV-2. Pediatric Infectious Disease Journal 2023. doi: 10.1097/INF.0000000000003972 (Epub). [Abstract]

Davies C, Marshall HS, Brotherton JM, McCaffery K, Kang M, Macartney K, Garland S, Kaldor J, Zimet G, Skinner SR, Study Group. Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: a cluster-randomized trial. Preventive Medicine 2023:107542. doi: 10.1016/j.ypmed.2023.107542 (Epub). [Full text]

Dalmau M, Ware R, Field E, Sanguineti E, Si D, Lambert S. Effect of COVID-19 pandemic restrictions on chlamydia and gonorrhoea notifications and testing in Queensland, Australia: an interrupted time series analysis. Sexually Transmitted Infections 2023. sextrans-2022-055656. doi: 10.1136/sextrans-2022-055656 (Epub). [Full text]

Pillsbury A, Phillips A, Deng L, Quinn H, Macartney K, Gidding H. Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines. Vaccine 2023:S0264-410X:00441-3. doi: 10.1016/j.vaccine.2023.04.041. (Epub). [Full text]

Koirala A, Winkler NE, Quinn HE, Gardiner E, Liu B, Forbes J, Sharpe C, van Tussenbroek T, Wood N, Macartney K . Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet Regional Health - Western Pacific 2023. doi: 10.1016/j.lanwpc.2023.100736 (Epub). [Full text]

Jayasinghe S, Patel C, Armstrong L, Chiu C, Macartney K, Flanagan K, Gibney K, Giles M, Crawford N, Cheng A, Blyth C. ATAGI Targeted Review 2021: the national COVID-19 vaccination program. Commun Dis Intell (2018). 2023;47. doi: 10.33321/cdi.2023.47.20. [Full text]

Huang YA, Li-Kim-Moy J, Jayasinghe S, Chiu C, Macartney K, Liu B, Burns P, Giles M, Crawford N. ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia. Commun Dis Intell (2018). 2023;47. doi: 10.33321/cdi.2023.47.21. [Full text]

Arkell P, Sheridan SL, Martins N, Tanesi MY, Gomes N, Amaral S, Oakley T, Solano V, David M, Draper AD, Sarmento N, da Silva E, Alves L, Freitas C, de Neri Machado F, Gusmão CA, da Costa Barreto I, Fancourt NS, Macartney K, Yan J, Francis JR. Vaccine preventable disease seroprevalence in a nationwide assessment of Timor-Leste (VASINA-TL) - study protocol for a population-representative cross-sectional serosurvey. BMJ 2022. doi: 10.1101/2022.12.23.22283897 . [Full text]

Basseal JM, Bennett CM, Collignon P, Currie BJ, Durrheim DN, Leask J, McBryde ES, McIntyre P, Russell FM, Smith DW, Sorrell TC, Marais BJ. Key lessons from the COVID-19 public health response in Australia. The Lancet Regional Health Western Pacific 2023;30:100616. doi: 10.1016/j.lanwpc.2022.100616. [Full text]

Kermond RF, Ozimek-Kulik JE, Kim S, Alexander SI, Hahn D, Kesson A, Wood N, McCarthy HJ, Durkan AM. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients. Pediatric Nephrology 2023;38:859-866. doi: 10.1007/s00467-022-05679-y. [Full text]